{"id":3041,"date":"2021-07-07T08:39:21","date_gmt":"2021-07-07T06:39:21","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=3041"},"modified":"2021-07-07T08:39:21","modified_gmt":"2021-07-07T06:39:21","slug":"tratamientos-con-ieca-ara-ii-y-covid-19","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2021\/07\/07\/tratamientos-con-ieca-ara-ii-y-covid-19\/","title":{"rendered":"Tratamientos con IECA\/ARA II y COVID-19"},"content":{"rendered":"<p data-adtags-visited=\"true\">Jos\u00e9 Bascu\u00f1ana, del Servicio de Medicina Interna, es uno de los autores del art\u00edculo publicado en el <em>Journal of Clinical Medicine<\/em> sobre la<img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" alt=\"logo12\" width=\"230\" height=\"157\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/> <a href=\"https:\/\/www.mdpi.com\/2077-0383\/10\/12\/2642\" target=\"_blank\" rel=\"noopener\">angiotensina y la mortalidad de pacientes COVID-19<\/a>.<\/p>\n<p data-adtags-visited=\"true\">Se trata de un estudio retrospectivo, observacional y multic\u00e9ntrico que eval\u00faa a los pacientes con COVID-19 tratados con inhibidores de la enzima convertidora de angiotensina (IECA) y antagonistas de los receptores de angiotensina II (ARA II) durante la primera ola de la pandemia. Se incluyeron 11.205 pacientes, con una edad media de 67 a\u00f1os y 57% varones. Se consider\u00f3 la necesidad de ventilaci\u00f3n mec\u00e1nica, de ventilaci\u00f3n mec\u00e1nica no invasiva, el ingreso en UCI y la mortalidad. El tratamiento con IECA\/ARA II durante la hospitalizaci\u00f3n por COVID-19 se asoci\u00f3 con una menor mortalidad. Los beneficios fueron mayores en los hipertensos, los que continuaron el tratamiento y los que tomaban ARA.<\/p>\n<p data-adtags-visited=\"true\"><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Jos\u00e9 Bascu\u00f1ana, del Servicio de Medicina Interna, es uno de los autores del art\u00edculo publicado en el Journal of Clinical Medicine sobre la angiotensina y la mortalidad de pacientes COVID-19. Se trata de un estudio retrospectivo, observacional y multic\u00e9ntrico que eval\u00faa a los pacientes con COVID-19 tratados con inhibidores de \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2021\/07\/07\/tratamientos-con-ieca-ara-ii-y-covid-19\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-N3","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3041"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=3041"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3041\/revisions"}],"predecessor-version":[{"id":3042,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/3041\/revisions\/3042"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=3041"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=3041"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=3041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}